HCW Biologics Inc. HCWB
1.04 USD 0.00 (-0.37%)
Nov 6, 2026, 9:52 AM EST
1.02 Day range 1.04
1.01 52-week range 23.94
- YTD
- -82.23%
- 1 year
- -94.80%
News
globenewswire.com HCW Biologics Presents Newly Identified Distinctive Features of Its Lead T Cell Engager Candidate Built with Company's Proprietary T-Cell Engager Platform, Further Supporting Its Use in Treating Solid Tumors at the Society for Immunotherapy of Cancer's 41st Annual Meeting HCW11-018b induces/promotes tertiary lymphoid structure formation inside tumors HCW11-018b converts immunological “cold” tumors into “hot” tumors HCW11-018b was generated using the Company's non-Fc…
benzinga.com HCW Biologics Announces It Secured $10M In Cash To Finance Its Phase 1 Trial Of HCW9302 To Treat Alopecia Areata HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ:HCWB), a U.S.-based clinical-stage biopharmaceutical company and leading developer in novel multi-functional fusion immunotherapeutics,…
globenewswire.com HCW Biologics Secures up to $10.0 Million in Cash Through Debt Financing Provides funding needed to complete HCW9302 Phase 1 study in alopecia areata and establish Recommended Phase 2 Dose Provides funding needed to complete HCW9302 Phase 1 study in alopecia areata and…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares rose 93.3% to $2.03 during Tuesday's pre-market session. The company's market cap stands at $2.6 million. Scinai Immunotherapeutics (NASDAQ:SCNI)…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Onconetix (NASDAQ:ONCO) stock increased by 10.3% to $1.14 during Friday's after-market session. The market value of their outstanding shares is at $3.9 million. Bullfrog AI Hldgs…
benzinga.com HCW Biologics Prices $1.5M Private Placement Of 903,614 Units At $1.6599 Per Unit Company agreed to issue and sell an aggregate of 903,614 units (the "Units"), with each Unit consisting of (i) one pre-funded warrant (a "Pre-Funded Warrant") to purchase one share of the Company’s- benzinga.com HCW Biologics Signs Agreement With Akron Biotech To Commercialize HCW11-006 To Use As Reagent For New Method Of Human CAR-T Cells Production To Treat Cancer HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ:HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on developing novel fusion immunotherapeutics to treat autoimmune
benzinga.com HCW Biologics, Partners Identify TGF-β Trap, IL-15 Fusion As Novel Moiety With Potential Applications Against Diseased Cell, Viral Infections HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on developing novel fusion immunotherapeutics to treat autoimmune- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Tenon Medical (NASDAQ:TNON) shares moved upwards by 70.3% to $9.28 during Tuesday's after-market session. The market value of their outstanding shares is at $3.2 million. The company's, Q2…
benzinga.com HCW Biologics Says Q1 2026 Financial Statements Should No Longer Be Relied Upon; Error In Two-Class Method For EPS Calculation Identified; Errors Constitute Material Misstatement Of EPS; EPS Of $2.19 Per Share Overstated By $0.80 Per Share For Q1 2026; Material Weakness In Technical Accounting Review Control Identified On August 10, 2026, the Audit Committee of the Board of Directors (the "Audit Committee") of HCW Biologics Inc. (the "Company"), in consultation with management and the Company’s independent…- benzinga.com HCW Biologics Prices $1.6M Private Placement Of 618,682 Units At A Price Of $2.5849/Unit HCW Biologics Inc. (the "Company" or "HCW Biologics"), (NASDAQ:HCWB), a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to treat autoimmune diseases,…
benzinga.com HCW Biologics Requests For Type B Meeting With FDA To Discuss Development, Regulatory Path For Its HCW11-018b Candidate To Treat Solid Tumors HCW Biologics Inc. (the "Company" or "HCW Biologics"), (NASDAQ:HCWB), a U.S.-based clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to treat diseases…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market session. The market value of their outstanding shares is at $8.2 million. Barinthus Biotherapeutics…- benzinga.com HCW Biologics Regains Nasdaq Compliance After Announcing 1-For-6 Reverse Stock Split, Effective June 30 HCW Biologics Inc. (the "Company" or "HCW Biologics") (Nasdaq: HCWB), a U.S.-based clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat
benzinga.com HCW Biologics Announces 1-For-6 Reverse Stock Split, Effective June 30 HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ:HCWB), a U.S.-based clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat…
benzinga.com Microcap HCW Biologics' Therapy Shows Early Promise Against Autoimmune Hair Loss HCW Biologics reports positive Phase 1 data for HCW9302, with all 2nd-cohort alopecia patients showing a clinical response.- benzinga.com HCW Biologics Says Preliminary Human Data For The First Two Dose Cohorts From Its Dose-escalating Phase 1 Trial Of HCW9302 For Alopecia Areata Shows Clinical Response After Single Dose Administration Potentially best-in-class IL-2 based treatment for autoimmune diseases by expanding and activating regulatory T cellsReadout for dose-escalating clinical study for first two dose cohortsAll…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com HCW Biologics Files Prospectus For Offering 5.69M Common Shares https://www.sec.gov/Archives/edgar/data/1828673/000149315226027656/forms-1.htm
- benzinga.com Maxim Group Maintains Buy on HCW Biologics, Raises Price Target to $5 Maxim Group analyst Michael Okunewitch maintains HCW Biologics (NASDAQ:HCWB) with a Buy and raises the price target from $2 to $5.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session 
benzinga.com HCW Biologics Exercises Options To Regain Full Ex Vivo Rights HCW9206, HCW9201 From Wugen HCW Biologics Inc. (the "Company") (NASDAQ:HCWB), a clinical-stage biopharmaceutical company developing first-in-class fusion immunotherapeutics for autoimmune diseases, cancer, and…- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Why Is HCW Biologics Stock Surging On Friday? HCW Biologics Inc. (NASDAQ: HCWB) stock rallies on Friday as a $4 million private placement offering boosts liquidity for its clinical trials.- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why HCW Biologics Stock Is Surging On Thursday? HCW Biologics Inc. (NASDAQ:HCWB) stock is rallying after securing a $4 million private placement to fund its clinical pipeline. Read the full market breakdown.
benzinga.com HCW Biologics Prices Private Placement Of 2.84M Units At $1.405 Each HCW Biologics Inc. (the "Company" or "HCW Biologics"), (NASDAQ:HCWB), a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to treat autoimmune, cancer and…- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com Why HCW Biologics Stock Is Falling On Tuesday? HCW Biologics Inc. (NASDAQ: HCWB) stock falls on Tuesday. Retail traders lock in gains after a 262% surge driven by Q1 earnings and pipeline updates.
benzinga.com Why Agilysys Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial results and issuing positive sales guidance. Other notable gainers and losers in pre-market…
benzinga.com What's Going On With HCW Biologics Stock Monday? HCW Biologics (HCWB) reports Q1 EPS of $0.37 and $6.54M in sales. Find out why the stock skyrocketed and what's next.
benzinga.com Why LiveRamp Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $2.2 billion. Other gainers include SBFM, NXXT, GOVX, CREG, PMI, ZDAI, GCTS, CMPS, and DXYZ. BTM,…
benzinga.com Why Is HCW Biologics Stock Gaining Today? HCW Biologics shares soared Friday after the company reported stronger quarterly results, advanced a key licensing deal and reaffirmed upcoming autoimmune clinical data milestones despite ongoing…- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Crude Oil Surges 3%; RBC Bearings Earnings Top Views US stocks down, S&P 500 falls 1%; Dow down 1.08%, NASDAQ down 1.42%. Energy shares up 1.5%; materials stocks down 2.1%. RBC Bearings beats Q1 estimates.
benzinga.com Dow Tumbles 500 Points; NY Manufacturing Activity Surges In May Dow Jones falls 500 points, S&P drops 1.29%, NASDAQ down 1.79%. Energy shares rise 1.2%, tech stocks fall 2.2%. NY Empire State Manufacturing Index at 19.6.- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why Figma Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket Figma Inc (NYSE: FIG) shares rose 10.6% in pre-market trading after beating Q1 revenue and earnings estimates and raising FY26 sales guidance.
benzinga.com HCW Biologics (HCWB) Stock Is Trending Overnight — Here's Why It Moved Over 122% In After-Hours Session HCW Biologics Inc. surged 122.55% in after-hours trading after reporting first-quarter EPS that sharply exceeded analyst expectations.- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com HCW Biologics Q1 EPS $0.37 Beats $(0.44) Estimate, Sales $6.543M Up From $5.065K YoY HCW Biologics (NASDAQ:HCWB) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $(0.44) by 184.09 percent. This is a 840 percent increase over losses of…
- benzinga.com HCW Biologics Announces Its HCW11-040 Pembrolizumab-based Fusion Immunotherapeutic Discovered To Prevent Bronchopulmonary Dysplasia During IND-Enabling Trials HCW Biologics Inc. (the "Company" or "HCW Biologics"), (NASDAQ:HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on developing novel fusion immunotherapeutics to treat autoimmune…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Why Globalstar Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket Amazon may acquire Globalstar Inc., shares soared in pre-market trading. Other gainers include Turbo Energy SA, Semilux International Ltd, Visionary Holdings Inc, and more. Losers are PMGC Holdings…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session